# BOSENTAN
> **ANDA205173** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2020-01-15
## Drug
- **FDA Application Number:** ANDA205173
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BOSENTAN
- **Generic name:** Bosentan
- **Active ingredients:** BOSENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2020-01-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205173)
---
*AI Analytics · CC0 1.0*